Researchers Flip Pharmaceutical AI to Create 40,000 Biowarfare Agents

Audrey Carleton

Machine learning has offered the pharmaceutical industry a lot. It automated the drug discovery process, making it easier to identify proteins that indicate disease, predicting molecules that will effectively bind to them to treat it, and shortened the process by which essential medicines—like COVID-19 vaccines—get rolled out.

Machine learning has also made it easier to make bioweapons at scale using these same tools, a group of researchers warned in the journal Nature Machine Intelligence this month. In the paper, the authors trained a drug development tool to identify  40,000 potential bioweapons in just six hours.

Latest articles

www.womensvoices.org A recent report by the nonprofit Women’s Voices for the Earth...
www.womensvoices.org Period products are used on and in highly sensitive and absorptive...
www.womenvoices.org In recent years, the use of nanosilver as an antibacterial agent...
Carla Peeters Thus far scientific literature on graphene-derived products is mainly focused...
Outraged Human GRAPHENE FAMILY NANOPARTICLES can be delivered into bodies by intratracheal...

Thank you!

The form has been submitted successfully!